Answers are grounded in this paper and cite their sources.
Candida auris, an emerging multidrug-resistant fungal pathogen, poses a significant diagnostic and infection control challenge with limited identification methodologies. To overcome this, we developed and validated a rapid, specific, and direct colony real-time PCR assay for C. auris identification without DNA extraction. Species-specific primers were designed using comparative genomics and subjected to rigorous experimental validations. The optimized assay using a selected primer pair (Candida-auris-5F/5R) successfully identified C. auris directly from the cultured colonies within two hours. It demonstrated high specificity against eight clinically relevant non-auris Candida species, and sufficient sensitivity (as low as 100 cells/reaction) for routine laboratory testing. This method significantly reduced the turnaround time, labor, and costs compared to conventional molecular techniques that require DNA extraction. Acknowledging the recent emergence of Clade I strains in Japan, the selected primer pairs and positive controls were distributed nationally to all 59 regional public health institutes by January 2025, establishing a standardized surveillance system. This assay is expected to play a key role in timely detection of C. auris, thereby improving patient care and outbreak management.
No takes yet. Share an insight, caveat, or question.
Umeyama et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: